Evidence map›Paper›PMID 26251696›Full record

ArticleSkeletal muscle2015

Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages.

Tatiana V Cohen, Gina M Many, Bryan D Fleming, Viola F Gnocchi, Svetlana Ghimbovschi, David M Mosser, Eric P Hoffman, Terence A Partridge

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Ghost messages: cell death signals spread.Cell communication and signaling : CCS · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Immunobiology of Inherited Muscular Dystrophies.Comprehensive Physiology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tatiana V CohenCenter for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 USA ; Center for Genetic Muscle Disorders, Kennedy Krieger Institute, 707 N. Broadway, Baltimore, MD 21205 USA ; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.ORCID 0000-0002-1354-2437
Gina M ManyCenter for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 USA.
Bryan D FlemingDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742 USA.
Viola F GnocchiCenter for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 USA.
Svetlana GhimbovschiCenter for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 USA.
David M MosserDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742 USA.
Eric P HoffmanCenter for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 USA.
Terence A PartridgeCenter for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 USA.
Children's National · USUniversity of Maryland, College Park · USKennedy Krieger Institute · US

Funding

NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation MedicineR24HD050846 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI KNOBLACH, SUSAN M · 2005 to 2014
$8.6M
Regulatory macrophages and the host inflammatory responseR01GM102589 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI MOSSER, DAVID M · 2013 to 2016
$1.2M
NICHD NIH HHS R24 HD050846NIGMS NIH HHS R01 GM102589
6 · The paper itself

Abstract

backgroundLoss-of-function mutations in the dysferlin gene (DYSF) result in a family of muscle disorders known collectively as the dysferlinopathies. Dysferlin-deficient muscle is characterized by inflammatory foci and macrophage infiltration with subsequent decline in muscle function. Whereas macrophages function to remove necrotic tissue in acute injury, their prevalence in chronic myopathy is thought to inhibit resolution of muscle regeneration. Two major classes of macrophages, classical (M1) and alternative (M2a), play distinct roles during the acute injury process. However, their individual roles in chronic myopathy remain unclear and were explored in this study.

methodsTo test the roles of the two macrophage phenotypes on regeneration in dysferlin-deficient muscle, we developed an in vitro co-culture model of macrophages and muscle cells. We assayed the co-cultures using ELISA and cytokine arrays to identify secreted factors and performed transcriptome analysis of molecular networks induced in the myoblasts.

resultsDysferlin-deficient muscle contained an excess of M1 macrophage markers, compared with WT, and regenerated poorly in response to toxin injury. Co-culturing macrophages with muscle cells showed that M1 macrophages inhibit muscle regeneration whereas M2a macrophages promote it, especially in dysferlin-deficient muscle cells. Examination of soluble factors released in the co-cultures and transcriptome analysis implicated two soluble factors in mediating the effects: IL-1β and IL-4, which during acute injury are secreted from M1 and M2a macrophages, respectively. To test the roles of these two factors in dysferlin-deficient muscle, myoblasts were treated with IL-4, which improved muscle differentiation, or IL-1β, which inhibited it. Importantly, blockade of IL-1β signaling significantly improved differentiation of dysferlin-deficient cells.

conclusionsWe propose that the inhibitory effects of M1 macrophages on myogenesis are mediated by IL-1β signals and suppression of the M1-mediated immune response may improve muscle regeneration in dysferlin deficiency. Our studies identify a potential therapeutic approach to promote muscle regeneration in dystrophic muscle.

Indexed as

Cell-cell interactionsDysferlinLGMD2BMacrophagesMuscular dystrophyMyoblastsSkeletal muscle

Identifiers

PMID26251696
PMCPMC4527226
OpenAlexW2134770275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.